Get started

Biotechpenny

VOR - a b iotechnology penny stock LONGVOR is a on daily chart. It is a biotechnology startup which is burning cash. As a resut this is a speculative long trade for this company with products to treat leukemia ( blood cancer). Price has crossed over the POC line of the volume profile and also completed an anchored mean VWAP cross over. The Price Momentum Oscillator is reversing and buying volume has increased since the earnings report showed less of a loss than forecasted. I see 30% upside to the high pivot in mid-January. In conjunction with stop- loss set at the mean anchored VWAP this is a R to r of about 3.
NASDAQ:VOR
by AwesomeAvani
LCTX gets upgrade and is technically setup LONGLCTX on the weekly chart here has been falling since late 2021 and found support at the bottom of the high volume area of the volume profile and ranged between it and the POC line for the past 18 months. The is a high end clinically active biotechnology firm using stem cells to produce therapeutic cell lines . ( One experiment using the mammary glands of cows imbedded with cells that make insulin to make a weak milk solution containing insulin and then concentrate it for cheap insulin is quite remarkable- ) How about some special milk for to have with your sugar buzz) see more in the here link en.wikipedia.org Anyway, price rose into triple confluence- the anchored mean VWAP, the POC line, the upper boundary of the high volume area. A new analysis targets 7. Smart money is paying attention. My smart money is paying a lot of attention. I understand the science and the market that LCTX could reach in due time. I am not an insider but close. Enough said. My target is the tweezer tops of 2022 at 2.5 and so 65-70% upside in the near to intermediate term and after that maybe the analysis will revise the target up or down I am guessing the former.
AMEX:LCTXLong
by AwesomeAvani
MYO can Myomo continue the push to the earnings report?MYO had impressive week gaining over 35%. It is a volatile penny biotechnology stock with good earnings back in November new due for another report. On a 120 minute chart with relative volatility and volume indicators and a volume profile added. The volume and volativlty of this past week's move is obvious. Price gain has slowed on the approach to the POC line of the volume profile which appears to be resistance. Price may break that resistance but could get rejected there. I plan to buy MYO long on a break of resistance with a buy stop set at 4.04 and a stop loss at 3.96. If MYO rises and gets over 4.04 the order should fill and if it retests the POC line as support and the support fails, the stop will close the trade. My expectation however is for the earnings run to take it to the level of the pivot high in early January for a 25% gain.
AMEX:MYOLong
by AwesomeAvani